pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy
暂无分享,去创建一个
Xing-jie Liang | Chan Li | C. Okeke | A. Mozhi | I. Ahmad | Anbu Mozhi
[1] In‐San Kim,et al. Double-Chambered Ferritin Platform: Dual-Function Payloads of Cytotoxic Peptides and Fluorescent Protein. , 2016, Biomacromolecules.
[2] David John Adams,et al. Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[3] Yaping Li,et al. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. , 2014, Biomaterials.
[4] Ming Zhou,et al. A Mitochondria‐Targeting Gold–Peptide Nanoassembly for Enhanced Cancer‐Cell Killing , 2013, Advanced healthcare materials.
[5] E. Ruoslahti,et al. Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Xing-jie Liang,et al. Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo. , 2013, Nano letters.
[7] E. Ruoslahti,et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[8] Holger Gerhardt,et al. Basic and Therapeutic Aspects of Angiogenesis , 2011, Cell.
[9] D. S. Lee,et al. Evaluation of pH-sensitive poly(β-amino ester)-graft-poly(ethylene glycol) and its usefulness as a pH-sensor and protein carrier. , 2011, Macromolecular bioscience.
[10] Gonen Ashkenasy,et al. Light induced drug delivery into cancer cells. , 2011, Biomaterials.
[11] W. Arap,et al. Targeting neuropilin-1 in human leukemia and lymphoma. , 2011, Blood.
[12] Ick Chan Kwon,et al. Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[13] Erkki Ruoslahti,et al. Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.
[14] D. Boturyn,et al. Synthesis and Biological Characterisation of Targeted Pro‐Apoptotic Peptide , 2008, Chembiochem : a European journal of chemical biology.
[15] Erkki Ruoslahti,et al. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. , 2008, Cancer research.
[16] Eun Seong Lee,et al. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine). , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[17] E. Ruoslahti,et al. Molecular changes in the vasculature of injured tissues. , 2007, The American journal of pathology.
[18] M. Yarmush,et al. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells. , 2007, Cancer research.
[19] D. S. Lee,et al. pH-Responsive PEG-Poly(β-amino ester) Block Copolymer Micelles with a Sharp Transition , 2006 .
[20] Peter Carmeliet,et al. Angiogenesis in life, disease and medicine , 2005, Nature.
[21] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[22] Erkki Ruoslahti,et al. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. , 2003, Cancer cell.
[23] Erkki Ruoslahti,et al. Targeting the prostate for destruction through a vascular address , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Ruoslahti. Specialization of tumour vasculature , 2002, Nature Reviews Cancer.
[25] J. Mai,et al. A proapoptotic peptide for the treatment of solid tumors. , 2001, Cancer research.
[26] Robert Langer,et al. Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .
[27] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[28] J R Griffiths,et al. Causes and consequences of tumour acidity and implications for treatment. , 2000, Molecular medicine today.
[29] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[30] Erkki Ruoslahti,et al. Anti-cancer activity of targeted pro-apoptotic peptides , 1999, Nature Medicine.
[31] V. V. van Hinsbergh,et al. Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] K. Akiyoshi,et al. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide , 1997 .
[33] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[34] London Wc,et al. De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity , 1996 .
[35] D. Leeper,et al. Extracellular pH distribution in human tumours. , 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[36] I. V. van Stokkum,et al. Estimation of protein secondary structure and error analysis from circular dichroism spectra. , 1990, Analytical biochemistry.
[37] M. Winnik,et al. Fluorescence probe techniques used to study micelle formation in water-soluble block copolymers , 1990 .
[38] R. Jain,et al. Extravascular transport in normal and tumor tissues. , 1986, Critical reviews in oncology/hematology.
[39] P. Heytler. uncoupling of oxidative phosphorylation by carbonyl cyanide phenylhydrazones. I. Some characteristics of m-Cl-CCP action on mitochondria and chloroplasts. , 1963, Biochemistry.